[Prognostic Value of STMN1 Expression in Non-small Cell Lung Cancer: A Meta-analysis] [0.03%]
STMN1在非小细胞肺癌的表达及其预后价值meta分析
Mengjie Li,Qinghua Zhou
Mengjie Li
Background: Lung cancer is one of the malignant tumors with the highest morbidity and mortality rates worldwide, seriously threatening human health. Non-small cell lung cancer (NSCLC) accounts for more than 85% of all lun...
[Non-small Cell Lung Cancer Cell Line PC-9 Drug-resistant Mutant Cell Line Establishment and Validation of Their Sensitivity to EGFR Inhibitors] [0.03%]
人非小细胞肺癌PC-9细胞株耐药突变系的建立及其表皮生长因子受体酪氨酸激酶抑制剂敏感性检测
Tao Hu,Yang Lou,Mingbo Su
Tao Hu
Background: Mutations in the structural domain of the epidermal growth factor receptor (EGFR) kinase represent a critical pathogenetic factor in non-small cell lung cancer (NSCLC). Small-molecule EGFR-tyrosine kinase inhi...
[Mechanism of Bone-metastatic LUAD Cells Promoting Angiogenesis Through HGF/YAP Signaling Pathway] [0.03%]
[骨转移LUAD细胞通过HGF/YAP信号通路促进血管生成的作用机制]
Yan Deng,Rong Qiu,Xingyu Liu et al.
Yan Deng et al.
Background: The early stages of tumor bone metastasis are closely associated with changes in the vascular niche of the bone microenvironment, and abnormal angiogenesis accelerates tumor metastasis and progression. However...
[Clinical Practice Guidelines for the Management of Brain Metastases from Non-small Cell Lung Cancer with Actionable Gene Alterations in China (2025 Edition)] [0.03%]
中国非小细胞肺癌脑转移可靶向基因突变临床实践指南（2025版）
Lung Cancer Medical Education Committee of Chinese Medical Education Association;Brain Metastasis Collaboration Group, Youth Specialists Committee of Lung Cancer of Beijing Medical Reward Foundation
Lung Cancer Medical Education Committee of Chinese Medical Education Association;Brain Metastasis Collaboration Group
Brain metastasis has emerged as a significant challenge in the comprehensive management of patients with non-small cell lung cancer (NSCLC), particularly in those harboring driver gene mutations. Traditional treatments such as radiotherapy ...
[Erratum: Establishment of Human Lung Adenocarcinoma Radioresistant Cell Lines and the Mechanism of Radioresistance] [0.03%]
人肺腺癌放射耐受细胞系的建立及其耐受机制的研究 Erratum
Editorial Office of Chinese Journal of Lung Cancer
Editorial Office of Chinese Journal of Lung Cancer
This corrects the article DOI: 10.3779/j.issn.1009-3419.2023.102.08.
[Research and Progress on the Association of Porphyromonas gingivalis with Lung Cancer] [0.03%]
牙龈卟啉单胞菌与肺癌相关性的研究进展
Yuanyuan Yin,Jie Zhang,Qiang Guo et al.
Yuanyuan Yin et al.
Porphyromonas gingivalis is a key pathogenic microorganism that triggers periodontitis. It is closely associated with oral diseases such as chronic periodontitis and recently found to have a significant correlation with the occurrence, prog...
[Application of Patient-reported Outcomes and Shared Decision-making in Thoracic Surgery] [0.03%]
[患者报告结局和共同决策在胸外科手术中的应用]
Weihao Chen,Mengni Zhang,Cheng Shen
Weihao Chen
Thoracic surgery encompasses the diagnosis and treatment of various chest diseases such as lung cancer, esophageal cancer, and mediastinal tumors. The treatment plans for these diseases are complex and often involve a combination of surgery...
Zhanrui Zhang,Hongyu Liu,Jun Chen
Zhanrui Zhang
Ferroptosis is a recently discovered form of cell death that is distinct from apoptosis, characterized primarily by the accumulation of intracellular iron and increased levels of lipid peroxidation. Resistance of tumor cells to ferroptosis ...
[Advances in the Application of Adjuvant Chemotherapy and Targeted Therapy in Postoperative Patients with Stage I Lung Adenocarcinoma] [0.03%]
术后I期肺腺癌患者辅助化疗与靶向治疗进展
Ke Zhao,Chao Guo,Yeye Chen et al.
Ke Zhao et al.
Lung cancer is one of the main causes of cancer burden and death in China, with nearly 800,000 newly diagnosed lung cancer patients each year, nearly half of whom are lung adenocarcinoma (LUAD) patients. According to current clinical guidel...
[Research Progress and Perspectives of Antibody-drug Conjugates Targeting Trophoblast Cell Surface Antigen-2 in Advanced Non-small Cell Lung Cancer] [0.03%]
靶向滋养层细胞表面抗原-2的抗体药物偶联物治疗晚期非小细胞肺癌的研究进展与展望
Jingyan Xu,Jiaqi Liu,Shiqi Mei et al.
Jingyan Xu et al.
Non-small cell lung cancer (NSCLC) remains a significant global health burden, and there is an urgent need for new treatment options. Trophoblast cell surface antigen-2 (TROP-2), a target closely associated with NSCLC prognosis, has become ...